Can you trust the Directors of LIC's to do the right thing?
One aspect of the recent sensational events regarding Valeant Pharmaceuticals International provides a strong debating point over the governance of externally managed listed investment companies, with real relevance in Australia. Might be time to re-examine the prospectuses you subscribed to in the last two years.
Never miss an update
Enjoy this wire? Hit the ‘like’ button to let us know.
Stay up to date with my current content by
following me below and you’ll be notified every time I post a wire
Welcome to Livewire, Australia’s most trusted source of investment insights and analysis.
To continue reading this wire and get unlimited access to Livewire, join for free now and become a more informed and confident investor.
Already have an account? Sign in here
Advertisement
Andrew has 38 years experience as on the buy-side, sell-side and corporate investing. Andrew currently runs East 72 Holdings, a unique closed-end internally managed global long/short equity fund which is listed on NSX.
3 topics
Andrew has 38 years experience as on the buy-side, sell-side and corporate investing. Andrew currently runs East 72 Holdings, a unique closed-end internally managed global long/short equity fund which is listed on NSX.
Expertise
Andrew has 38 years experience as on the buy-side, sell-side and corporate investing. Andrew currently runs East 72 Holdings, a unique closed-end internally managed global long/short equity fund which is listed on NSX.
Expertise
Comments
Comments
Sign In or Join Free to comment
most popular
Equities
Paul Moore's stock to buy and hold for the next 25 years
Livewire Markets
Equities
A contrarian assessment of Macquarie Group
Leithner & Company Ltd
Equities
It won't get any better from here for Aussie banks
Livewire Markets